Clinical Trials
34
Active:15
Completed:16
Trial Phases
2 Phases
Phase 1:21
Phase 3:12
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (33 trials with phase data)• Click on a phase to view related trials
Phase 1
21 (63.6%)Phase 3
12 (36.4%)Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio
Phase 1
Recruiting
- Conditions
- Healthy Male and Female Subjects
- Interventions
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Alvotech Swiss AG
- Target Recruit Count
- 351
- Registration Number
- NCT06732804
- Locations
- 🇦🇺
Veritus Research Pty Ltd, Bayswater, Australia
🇳🇿Investigational Site 0002, Auckland, New Zealand
🇳🇿NZCR, Christchurch, New Zealand
Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Alvotech Swiss AG
- Target Recruit Count
- 748
- Registration Number
- NCT06570772
- Locations
- 🇦🇷
Investigational Site 161704, Ciudad Autónoma de BuenosAires, Argentina
🇦🇷Investigational Site 161702, Cordoba, Argentina
🇦🇷Investigational Site 161701, Quilmes, Argentina
Pilot Study of AVT16 in Healthy Adult Subjects
- First Posted Date
- 2024-05-06
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Alvotech Swiss AG
- Target Recruit Count
- 18
- Registration Number
- NCT06400719
- Locations
- 🇳🇿
CCST, Christchurch, New Zealand
Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease
Phase 3
Completed
- Conditions
- Chorioretinal Vascular Disease
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Alvotech Swiss AG
- Target Recruit Count
- 35
- Registration Number
- NCT05986786
- Locations
- 🇬🇪
4001, Tbilisi, Georgia
AVT03 With Xgeva in Healthy Male Subjects
Phase 1
Completed
- Conditions
- This is a Phase I Study Conducted in Healthy Volunteers
- Interventions
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Alvotech Swiss AG
- Target Recruit Count
- 208
- Registration Number
- NCT05876949
- Locations
- 🇵🇱
Biokinetica, Józefów, Poland
🇿🇦Farmovs, Bloemfontein, South Africa
🇬🇧Richmond Pharmacology, London, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found